Plexus (PLXS) Set to Announce Earnings on Wednesday

Plexus (NASDAQ:PLXS) is set to post its quarterly earnings results after the market closes on Wednesday, July 24th. Analysts expect Plexus to post earnings of $1.28 per share for the quarter. Plexus has set its Q3 guidance at $1.22-1.37 EPS and its Q3 2024 guidance at 1.220-1.370 EPS.Individual interested in participating in the company’s earnings conference call can do so using this link.

Plexus (NASDAQ:PLXS) last announced its earnings results on Wednesday, April 24th. The technology company reported $0.94 EPS for the quarter, topping the consensus estimate of $0.87 by $0.07. The business had revenue of $966.90 million during the quarter, compared to the consensus estimate of $950.75 million. Plexus had a net margin of 2.54% and a return on equity of 10.77%. Plexus’s revenue was down 9.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.45 EPS. On average, analysts expect Plexus to post $4 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Plexus Stock Performance

Shares of PLXS stock opened at $118.37 on Tuesday. The company has a market capitalization of $3.24 billion, a price-to-earnings ratio of 32.70 and a beta of 0.90. The company has a debt-to-equity ratio of 0.15, a quick ratio of 0.64 and a current ratio of 1.51. The company has a 50-day simple moving average of $107.54 and a 200 day simple moving average of $100.69. Plexus has a 52 week low of $87.21 and a 52 week high of $120.26.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on PLXS. Stifel Nicolaus lifted their price objective on shares of Plexus from $90.00 to $95.00 and gave the stock a “hold” rating in a research note on Friday, April 26th. Benchmark lifted their price objective on shares of Plexus from $110.00 to $120.00 and gave the stock a “buy” rating in a research note on Friday, June 21st. Finally, Needham & Company LLC lifted their price objective on shares of Plexus from $107.00 to $114.00 and gave the stock a “buy” rating in a research note on Friday, April 26th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat, Plexus has a consensus rating of “Hold” and an average price target of $110.25.

Insider Activity

In other news, CFO Patrick John Jermain sold 4,750 shares of the business’s stock in a transaction that occurred on Wednesday, May 1st. The shares were sold at an average price of $100.43, for a total value of $477,042.50. Following the completion of the transaction, the chief financial officer now directly owns 42,932 shares in the company, valued at approximately $4,311,660.76. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, CEO Todd P. Kelsey sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, April 29th. The shares were sold at an average price of $102.10, for a total value of $102,100.00. Following the completion of the transaction, the chief executive officer now directly owns 113,810 shares in the company, valued at approximately $11,620,001. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Patrick John Jermain sold 4,750 shares of Plexus stock in a transaction that occurred on Wednesday, May 1st. The shares were sold at an average price of $100.43, for a total transaction of $477,042.50. Following the sale, the chief financial officer now directly owns 42,932 shares in the company, valued at $4,311,660.76. The disclosure for this sale can be found here. In the last ninety days, insiders sold 35,386 shares of company stock worth $3,749,884. 2.39% of the stock is currently owned by corporate insiders.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.